NIH confronts decades of neglect in women's health research and training

The National Institutes of Health (NIH) has admitted long-standing gaps in women's health research, particularly in menopause studies. For years, a lack of solid evidence has left key questions unanswered, prompting calls for better funding and more rigorous scientific work. Now, the agency is pushing for major changes in how medical schools train doctors and how researchers approach conditions affecting women.

In recent years, the NIH has highlighted how little is known about menopause and its impact on long-term health. Many studies have not been replicated properly, leaving doctors without clear guidance. To address this, the agency is funding new research into hormone therapy and its role in preventing chronic diseases during menopause.

Meanwhile, medical education is starting to catch up. Between 2021 and 2026, several top US medical schools launched specialised programs. The Mayo Clinic Alix School of Medicine introduced a Menopause Medicine Fellowship in 2022. A year later, the University of Colorado Anschutz Medical Campus created a Menopause Society-certified fellowship. In 2024, George Washington University School of Medicine added a Menopause and Hormone Therapy Certificate Program. The NIH also plans to award grants to schools that expand training on menopause, ensuring future doctors receive better preparation.

Beyond menopause, the NIH has poured over $500 million into studying heart attack symptoms in women. Unlike men, women often experience back pain, nausea, or lightheadedness during a heart attack. The agency is also calling for more research into autoimmune diseases, which disproportionately affect women, and wants scientists to work together more closely. Another major project involves sequencing the genomes of one million volunteers to uncover genetic links to diseases.

The NIH's push for stronger research and education aims to close long-standing gaps in women's health. New funding, training programs, and large-scale genetic studies are expected to improve diagnosis and treatment. With more doctors learning about menopause and heart disease risks, the changes could lead to better care for millions of women.